Insider Trading & Ownership of BeOne Medicines Ltd.

Location
Basel
Summary
The estimated value of insider holdings of BeOne Medicines Ltd. is at least $20,943,045 dollars as of 28 Sep 2021. BeOne Medicines Ltd. is the 10%+ Owner of LEAP THERAPEUTICS, INC. and owns shares of CYPHERPUNK TECHNOLOGIES INC. (CYPH) stock worth about $20.94M.
Signature
BeiGene, Ltd. /s/ Scott A. Samuels, SVP, General Counsel
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow BeOne Medicines Ltd. and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • BeOne Medicines Ltd. has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $20,943,045.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: LEAP THERAPEUTICS, INC. ($20,943,045).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of BeOne Medicines Ltd.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CYPH LEAP THERAPEUTICS, INC. 10%+ Owner $20,943,045 24 Sep 2021

Insider Transactions Reported by BeOne Medicines Ltd.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored